Company Filing History:
1 out of 1 
1 out of 9 Years Active: 2010
Title: Innovations of Xiaowei Zhu in Pharmaceutical Chemistry
Introduction
Xiaowei Zhu is a notable inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that address critical health issues. His work focuses on innovative solutions for treating various diseases, showcasing his expertise and dedication to improving healthcare.
Latest Patents
Xiaowei Zhu holds a patent for "C-glycosylisoflavones having alkylaminoalkoxyl substituent, preparation and use of the same." This invention relates to C-Glycosylisoflavones that possess alkylaminoalkoxyl substituents and their pharmaceutically acceptable salts. The patent outlines a process for preparing these compounds, which are used in pharmaceutical compositions for treating or preventing cardio- and cerebrovascular diseases. Additionally, these compounds are aimed at addressing diabetes mellitus and its complications, as well as chemical poisoning, particularly alcoholism. Xiaowei Zhu has 1 patent to his name.
Career Highlights
Throughout his career, Xiaowei Zhu has worked with prominent organizations, including Hainan Yangpu New & Special Medicine Co., Ltd. and the Institute of Radiation Medicine at the Academy of Military Medical Sciences. His experience in these institutions has allowed him to collaborate on various research projects and contribute to advancements in medical science.
Collaborations
Xiaowei Zhu has collaborated with esteemed colleagues such as Lin Wang and Qiujun Lu. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work in the pharmaceutical field.
Conclusion
Xiaowei Zhu's innovative contributions to pharmaceutical chemistry demonstrate his commitment to addressing significant health challenges. His patent on C-glycosylisoflavones highlights the potential for new treatments in critical areas of medicine. Through his career and collaborations, he continues to make strides in improving healthcare solutions.